Qube Research & Technologies LTD X Biotech Inc. Transaction History

Qube Research & Technologies LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$4.54 - $9.89 $248,542 - $541,428	-54,745 Reduced 80.91%	12,917 $66,000
Q1 2024 May 14, 2024	BUY	$4.03 - $8.13 $45,075 - $90,934	11,185 Added 19.8%	67,662 $550,000
Q4 2023 Feb 13, 2024	BUY	$3.56 - $4.65 $191,944 - $250,714	53,917 Added 2106.13%	56,477 $225,000
Q3 2023 Nov 13, 2023	BUY	$4.02 - $5.81 $10,291 - $14,873	2,560 New	2,560 $10,000
Q3 2022 Nov 14, 2022	SELL	$3.58 - $5.88 $6,436 - $10,572	-1,798 Reduced 12.5%	12,591 $46,000
Q2 2022 Aug 15, 2022	BUY	$5.13 - $9.2 $73,815 - $132,378	14,389 New	14,389 $81,000

4.87M

Ticker XBIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,439,300
Market Cap $203M
Description
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.